Антабус

Quick links to important sections

Антабус

Selected form

Treatment option: Alcoholism

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Антабус

Property Description
Active Ingredient Disulfiram
Form Oral dosage form (Tablets, Effervescent tablets)
Pharmacological Class Alcohol Antagonist Drug / Alcohol-sensitizing agent
Common Use Support in managing Alcohol Use Disorder (AUD)
Origin Synthetic Compound

Антабус: Identity and Pharmacological Classification

Антабус is a prescription-only medication primarily used to support individuals committed to abstaining from alcohol due to Alcohol Use Disorder (AUD). Its core component is the Disulfiram active ingredient. It is formally classified as an Alcohol Antagonist Drug, also known as an alcohol-sensitizing agent. Its value in long-term treatment protocols is clinically recognized, as Disulfiram is identified as an essential medicine for alcohol dependence management. This status indicates the medicine is used to meet essential public health needs for this condition.

This classification defines the drug's purpose: it acts as a physical barrier to drinking, reinforcing the patient's choice for abstinence. A typical application involves a patient voluntarily taking the medication to provide a chemical safeguard against impulsive consumption, reinforcing their commitment to a treatment plan focused on complete sobriety.


Composition and Available Pharmaceutical Form

The sole active ingredient is the synthetic compound Disulfiram, which has the molecular formula C10H20N2S4. It is a single-ingredient product delivered as an oral dosage form, most commonly in the form of a tablet or effervescent tablet, taken via the oral route of administration. The availability of the effervescent tablet option offers a specific differentiating factor for patients who require easier dissolution compared to standard oral tablets.

Disulfiram's ability to act as a chemical safeguard stems from its function as an ALDH inhibitor (aldehyde dehydrogenase inhibitor). In this role, Disulfiram is characterized by its effect of modifying the alcohol metabolism process. This function achieves its goal by altering the body’s chemistry when alcohol is ingested. This mechanism ensures that the physical consequences of drinking are immediate and strongly deterrent.

Regulatory References

  1. World Health Organization (WHO)

What side effects are possible with Антабус?

Possible Side Effects and Safety Information

Adverse reactions associated with this medicine are broadly categorized into those that occur due to its inherent pharmacological action and those resulting from an interaction with alcohol.

The Disulfiram-Alcohol Reaction

The most serious safety concern is the severe reaction that occurs when the medicine is combined with alcohol, which can be fatal. This reaction can be triggered by even small amounts of alcohol, including that found in mouthwash, tonics, or certain foods, and may persist for up to 14 days after the medicine is stopped. Symptoms of this reaction include intense flushing, throbbing headache, severe nausea and vomiting, sweating, chest pain, and difficulty breathing. Severe reactions may lead to cardiovascular collapse, respiratory depression, seizures, and death.

Adverse Reactions Not Related to Alcohol

Side effects not related to alcohol ingestion may involve several system-organ classes, including the nervous system, liver, and skin. These may include:

  • Common: Mild headache, drowsiness, fatigue, metallic or garlic-like taste in the mouth, and skin rash.
  • Serious: The medicine is officially documented to cause hepatotoxicity, including severe hepatitis and hepatic failure that may require liver transplantation or result in death. Other serious reactions include neurotoxicity, specifically peripheral neuropathy and optic neuritis, and psychotic episodes.

Safety Restrictions and Contraindications

Regulatory documents stipulate that the medicine is contraindicated in patients with severe myocardial disease, coronary occlusion, psychosis, or severe liver impairment. Caution is required in patients with conditions such as diabetes mellitus, epilepsy, hypothyroidism, or impaired kidney function. Safety notes mandate frequent blood tests to check liver function prior to and periodically during treatment.

Overdose and Emergency Response

Overdose Manifestations and Severe Outcomes

Overdose with Антабус (Disulfiram) is primarily characterized by severe toxicity affecting the Central Nervous System (CNS). Documented manifestations include acute signs such as drowsiness, lethargy, confusion, and ataxia, which can progress to seizures and profound coma. Gastrointestinal symptoms like nausea and vomiting are also reported in acute ingestion.

Overdose carries the risk of a life-threatening state, particularly due to severe neurotoxicity. High-dose or chronic exposure is associated with outcomes such as Polyneuropathy and Encephalopathy. The safety and efficacy of the medication have not been determined for the pediatric population.

Regulator-Mandated Emergency Actions

No specific antidote is known to be available for Disulfiram toxicity; therefore, the mainstay of treatment is strictly symptomatic and supportive care. This management often requires hospital monitoring, including continuous Electrocardiogram (ECG) monitoring and assessment of fluid and electrolyte balance.

Official regulatory guidance mandates immediate action following a suspected overdose. The patient or caregiver must seek urgent medical care and contact a poison control center. Immediate contact with emergency services is required if the person has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened.

Therapeutic Uses of Антабус

What Антабус Treats: Main Uses and Benefits

The primary therapeutic role of Антабус (Disulfiram) is to provide foundational support for individuals committed to recovering from Alcohol Use Disorder (AUD). Its utility is centered on addressing the behavioral difficulty of maintaining long-term sobriety. This medication is commonly used in the United States and globally for the treatment of AUD.

Therapeutic Scope

This medication is commonly applied in the chronic management of moderate to severe AUD, specifically targeting the symptoms of impulsive consumption and the inability to maintain complete abstinence from alcohol. The medication is considered relevant as it assists with reinforcing the patient's efforts toward sobriety, serving as a pharmacological deterrent.

Indications: Антабус is relevant for conditions characterized by periods of heightened symptoms related to alcohol dependence, being used for managing Alcohol Use Disorder and chronic alcohol dependence. This therapeutic strategy helps address symptom clusters related to impulsive consumption that may undermine a patient's recovery goals.

“The treatment primarily supports the patient during the long-term abstinence phase, may assist with maintaining a sense of stability when symptoms are more noticeable.”

Pharmacological Support and Benefit

Антабус acts as a unique chemical safeguard, reinforcing the patient's voluntary choice to abstain. It is considered relevant in clinical scenarios where an external deterrent may be necessary to address challenges associated with persistent relapse risk. This function supports the patient's efforts toward maintaining functional stability, which may assist with engagement in concurrent psychological therapies, and may help improve day-to-day comfort and supports general well-being during recovery.

Quick Fact: Support for Maintaining Abstinence

Eligibility and Restrictions for Use

Eligibility Profile: Official Regulatory Information

The regulatory eligibility profile for Disulfiram (Антабус) defines specific populations for whom use is permitted, restricted, or strictly prohibited. Use is generally allowed for adults committed to abstinence who have been alcohol-free for a minimum of 12 to 24 hours.


Populations for whom use is Contraindicated

Absolute prohibitions, as documented in official labeling, apply to patients with severe myocardial disease or uncompensated heart failure, psychoses, serious organic brain damage, or known hypersensitivity to Disulfiram or thiuram derivatives.

Ineligibility is immediate for individuals in a state of alcohol intoxication or those currently receiving metronidazole or paraldehyde. Advanced hepatic disease is also a contraindication.


Conditional Use and Age Rules

  • Pediatric Patients: Use is not established and generally not recommended for patients under 18 years of age.
  • Older Adults: Use requires extreme caution, often initiating at the lower dose range.
  • Pregnancy/Lactation: The drug is frequently contraindicated or reserved only when benefits clearly outweigh unestablished risks in pregnancy. It is not recommended during lactation due to unknown excretion into breast milk.
  • Condition-Specific: Conditions such as diabetes mellitus, epilepsy, and renal or hepatic insufficiency require the medicine to be used with extreme caution.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Disulfiram is strictly defined by regulatory authorities and centers on mandatory prohibitions and pharmacokinetic inhibition of co-administered medicines.

Formal Contraindications and Timing Rules

The most critical interaction is the severe, potentially life-threatening reaction caused by co-administration with Alcohol (Ethanol). This combination is formally classified as contraindicated and applies to all alcohol-containing preparations, including liquid oral medications, mouthwash, and certain food products. Official administration rules require a minimum of 12 hours of abstinence from alcohol before starting therapy. Furthermore, the risk of a reaction is documented to persist for up to 14 days following the final dose of Disulfiram.

Co-administration is also formally prohibited with Metronidazole due to the risk of confusion or psychosis, and with Paraldehyde.

Pharmacokinetic and CNS Interactions

Disulfiram is a documented metabolic inhibitor that decreases the clearance rate of certain co-administered drugs, leading to increased plasma concentrations. This pharmacokinetic interaction is observed with Phenytoin and its congeners, risking intoxication. Similarly, it inhibits the metabolism of oral anticoagulants such as Warfarin, resulting in an officially described increase in the anticoagulant effect and a prolonged prothrombin time.

Other documented exposure-modifying interactions include increases in serum levels of Theophylline and certain Benzodiazepines (e.g., Diazepam and Chlordiazepoxide). Pharmacodynamic interactions with drugs like Isoniazid may result in unsteadiness or changes in mental status, a documented CNS effect.

Mechanism of Action

The mechanism of action for Disulfiram (Антабус) is the permanent blockade of the body's natural pathway for ethanol metabolite clearance.

Irreversible Blockade of Ethanol Detoxification

The drug exerts its primary action by causing irreversible inhibition of the enzyme Aldehyde Dehydrogenase (ALDH2) in the liver. This enzyme is essential for the second step of alcohol metabolism: converting the highly toxic intermediate Acetaldehyde into Acetate. By permanently deactivating ALDH2, the body becomes unable to process the toxin upon consuming alcohol, leading to its rapid and massive accumulation.

Acetaldehyde-Driven Vasoactive Cascade

The systemic buildup of elevated Acetaldehyde levels initiates a physiological cascade, as this toxin is a strong vasoactive agent. The consequences include widespread vasodilation and a significant drop in blood pressure (hypotension). The acetaldehyde overload also contributes to gastrointestinal and sensory responses. Disulfiram also inhibits Dopamine beta-Hydroxylase (DBH), which contributes to the resulting compensatory tachycardia (increased heart rate) and the overall adrenergic response.

️ Mechanism Longevity through Enzyme Constraint

Due to the irreversible nature of the ALDH inhibition, the drug's mechanism is not dependent on its plasma half-life but rather on the time it takes the body to synthesize new, functional enzyme. This enzymatic constraint ensures the aversive physiological mechanism remains active for a prolonged duration, typically 7 to 14 days after the final dose, maintaining continuous metabolic incapacity to clear alcohol effectively.

Dosage and Administration Information

The medication, Disulfiram (Антабус), is administered via the oral route as a tablet. Administration must be initiated only after the patient has maintained complete abstinence from alcohol for at least 12 hours, a procedural prerequisite for treatment.

Treatment generally follows a titrated dosing regimen, beginning with a maximum initial dose of 500 milligrams (mg) administered once daily for the first one to two weeks. The regimen transitions to a maintenance dose ranging from 125 mg to 500 mg once daily. The maximum dose must not exceed 500 mg daily.

Administration Logistics

The frequency is typically once daily. If the patient experiences a sedative effect, the dose may be shifted from morning to bedtime. The tablets may be crushed and mixed with liquids like water, coffee, or juice to aid intake. If a dose is missed, the instruction is to skip the missed dose and resume the regular schedule, rather than taking a double amount.

Therapy is often a long-term commitment, continuing for months or even years. For older adults, cautious dose selection is generally advised, often starting at the low end of the dosing range. Use in pediatric patients (under 18) is not established and not generally recommended.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Антабус

This section provides a summary of the clinical research and scientific studies that have evaluated the use of Disulfiram, the active ingredient in Антабус, for Alcohol Use Disorder (AUD). It describes the types of research conducted, the outcomes they monitored, and the acknowledged limitations in the evidence base, without offering any clinical advice or interpretation.


Evidence for Use in Alcohol Use Disorder (AUD)

The primary research for Disulfiram was evaluated in studies of Alcohol Use Disorder (AUD). This evidence includes numerous Randomized Controlled Trials (RCTs) and Meta-Analyses. Most research has explored the outcomes in adult patients who were enrolled in concurrent psychosocial support programs.

The main outcomes research explored included behavioral measures of drinking. Studies monitored outcomes related to the rates of continuous alcohol abstinence and the time elapsed until the first instance of relapse. Findings describe patterns observed in the studies over time. When trials attempted to maintain a strict blind, the findings were mixed, and the results were reported to be inconsistent.


The Influence of Supervision and Study Design

The scientific literature highlights how the study setting and design were observed alongside the outcomes monitored for this medicine. Many studies that reported how symptoms evolved in the observed populations involved a high degree of clinical supervision during the medicine's administration. The patterns observed in the studies were reported to be closely linked to the research context and the comprehensive support systems provided to participants during the trials.


Long-Term Evidence and Follow-up Durations

Most of the foundational research was evaluated in studies with follow-up durations that were limited, typically concluding after a short to intermediate period, with 12 months often being the longest common timeframe. However, the scientific community notes that there is limited information for long-term outcomes regarding the durability of continuous abstinence for many years. Data that show patterns related to sustained sobriety far beyond the one-year mark are less frequently found in the highest quality evidence, meaning that certainty on these outcomes remains low.


What is Still Uncertain About the Research Base

Scientific evidence highlights what is known — and what is still uncertain. The quality of evidence varies across studies, and a key challenge is the high study heterogeneity across trials, which makes it difficult to draw uniform conclusions. Furthermore, data for certain groups remain insufficient, especially for female patients and individuals with a broader range of complex health conditions. The results apply only to the populations studied under the specific conditions of the trials.

Key Studies & References

  1. DailyMed: Disulfiram Tablet (Disulfiram) [FDA Structured Product Label]
  2. Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence (NICE Guideline NG113)

Frequently Asked Questions (FAQ)

Common questions about Антабус (FAQ)

Q: Are there different doses of Antabuse, and what determines the amount?

A: The prescribing information describes an initial dose followed by a subsequent, lower maintenance dose. The maintenance dose may be adjusted to the lower end of the range, often to minimize sedative effects as noted in official sources.

Q: Can Antabuse affect other mental health medications like antidepressants?

A: Regulatory documents state that Antabuse is a metabolic inhibitor, meaning it can slow down the body’s processing of certain co-administered drugs. Although specific classes like antidepressants are not universally listed, caution is advised for any combination that may result in unsteadiness or changes in mental status. Official information stresses the importance of disclosing all psychiatric medications to the healthcare provider.

Q: Does Antabuse interact with herbal supplements?

A: Official health information advises that patients must disclose all medicines they are using, including prescriptions, over-the-counter products, vitamins, and herbal supplements. This disclosure is important for the healthcare provider to assess potential interactions and monitor the patient appropriately.

Q: What household or cosmetic products contain alcohol that I need to be careful of?

A: Regulatory warnings indicate that you must avoid alcohol in all forms, including those where it is disguised or less obvious. The label explicitly names common items such as sauces, vinegars, cough mixtures, aftershave lotions, back rubs, and perfumes/colognes/toilet waters as products that must be avoided while on this medication.

Q: Is non-alcoholic beer safe to drink while on Antabuse?

A: The official product information strongly advises against consuming all alcohol-containing products. The severe disulfiram-alcohol reaction can be triggered by even small amounts of alcohol. Due to the presence of trace alcohol in some non-alcoholic beverages, they are not specifically classified as safe in regulatory information.

Q: Can alcohol be absorbed through the skin from things like hand sanitizer or cologne?

A: Official warnings advise caution with alcohol-containing products applied to the skin, such as after-shave or rubbing alcohol. The regulatory label warns that alcohol in these products may be absorbed into the body, which could potentially cause a localized reaction, as noted in the warnings.

Q: Can Antabuse be used by people who have diabetes?

A: Official regulatory documents state that Disulfiram should be used with extreme caution in patients with diabetes mellitus. This is due to the possibility of an accidental disulfiram-alcohol reaction, and because the drug may impact the management of the diabetes itself.

Q: What kind of monitoring, like blood tests, is needed while on Antabuse?

A: Frequent blood tests to check liver function are mandated prior to and periodically during treatment. Official sources typically recommend monitoring complete blood count and serum chemistries, in addition to mandated liver function tests.

Q: Can a minor amount of alcohol, like from a single sip, still trigger the reaction?

A: Yes, regulatory information indicates that the reaction can be caused by even very small amounts of alcohol. In fact, mild reactions have been documented to occur when the blood alcohol concentration is at a very low level.

Q: Does Antabuse actually 'cure' alcoholism, or is it just a deterrent?

A: According to official health authorities, Disulfiram is used to help an individual manage a drinking problem, but it is not considered a cure for alcoholism. Its primary role is to act as a chemical deterrent, reinforcing the patient's commitment to abstinence.

Q: Why is a medical ID card recommended for people taking Antabuse?

A: The official prescribing information suggests that patients carry an identification card. This card should state that the patient is taking the medicine, list the symptoms of the severe reaction, and provide contact information for a healthcare provider to be contacted in case of an emergency.

Q: What should I tell a new doctor or dentist about my Antabuse use?

A: It is important to inform any new doctor or dentist that you are taking Disulfiram. This disclosure is necessary, especially if you are scheduled to have surgery, including dental surgery, due to the potential for drug interactions.

Q: What is the risk of accidentally encountering alcohol in workplace chemicals or fumes?

A: Official warnings state that patients must be careful not to come in contact with or breathe in the fumes of chemicals that may contain alcohol. This includes common industrial products such as paint, paint thinner, varnish, or shellac.

Q: Why is abstinence for a certain period required before starting Antabuse?

A: Official administration rules require a minimum period of abstinence, typically 12 hours, before starting the medication. This is a critical prerequisite to ensure that any residual alcohol has cleared from the body, thereby preventing the severe disulfiram-alcohol reaction when the medication's effect begins.

Q: Can Antabuse affect how I drive or operate machinery?

A: Official warnings advise caution regarding driving or operating heavy machinery due to the risk of drowsiness, until the patient understands how the drug affects them.

Q: Do I need to avoid all products containing even denatured alcohol?

A: Official warnings are comprehensive and instruct patients to avoid all alcohol-containing products. The comprehensive warnings indicate that all alcohol-containing products, including denatured alcohol, are to be avoided to prevent a potential reaction.

Q: Can Antabuse affect sexual function or libido?

A: Official adverse reaction lists mention that impotence (erectile dysfunction) is a documented, though less common, side effect of the medication. Some labels also recommend monitoring for potential sexual dysfunction during therapy.

How should Антабус be stored and disposed of?

Storage and Handling Requirements

Requirement Type Official Regulatory Statement
Storage Temperature Store at 20 C to 25 C (68 F to 77 F), which is the USP Controlled Room Temperature range.
Environmental Protection Keep the tablets protected from excess heat, moisture, and direct light. Store in a dry place, not in the bathroom or near a sink.
Container and Handling Keep the medication in the original container it came in and ensure the container is tightly closed. Keep the product from freezing.
Child Safety The medicine must be stored out of the reach of children.

Disposal Instructions

Disposal must be conducted in accordance with local regulations for unused medicinal product or waste material. The FDA recommends disposing of the product through a drug take-back program when available. If a take-back program is not accessible, the product may be mixed with an undesirable substance (such as used coffee grounds or cat litter) and placed in a sealed container before discarding in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Антабус found in:

A-Z Index: